• search hit 3 of 5
Back to Result List

Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer : a large multi-centre study

  • Background: Oesophageal (OeC) and gastric (GC) cancer patients are treated with similar multimodal therapy and have poor survival. There remains an urgent clinical need to identify biomarkers to individualise patient management and improve outcomes. Therapy with immune checkpoint inhibitors has shown promising results in other cancers. Proposed biomarkers to predict potential response to immune checkpoint inhibitors include DNA mismatch repair (MMR) and/or Epstein–Barr virus (EBV) status. The aim of this study was to establish and compare EBV status and MMR status in large multi-centre series of OeC and GC. Methods: EBV was assessed by EBV-encoded RNA (EBER) in situ hybridisation and MMR protein expression by immunohistochemistry (IHC) in 988 OeC and 1213 GC from multiple centres. In a subset of OeC, microsatellite instability (MSI) was tested in parallel with MMR IHC. Results: Frequency of MMR deficiency (MMRdef) and MSI was low in OeC (0.8% and 0.6%, respectively) compared with GC (10.3%). None of the OeCs were EBER positive in contrast to 4.8% EBER positive GC. EBV positive GC patients were younger (p = 0.01), more often male (p = 0.001) and had a better overall survival (p = 0.012). MMRdef GC patients were older (p = 0.001) and showed more often intestinal-type histology (p = 0.022). Conclusions: This is the largest study to date indicating that EBV and MMRdef do not play a role in OeC carcinogenesis in contrast to GC. The potential clinical usefulness of determining MMRdef/EBV status to screen patients for eligibility for immune-targeting therapy differs between OeC and GC patients.
Metadaten
Author:Lindsay C. Hewitt, Imran Z. Inam, Yuichi Saito, Takaki Yoshikawa, Alexander Quaas, Arnulf H. Hölscher, Elfriede Bollschweiler, Gregorio E. Fazzi, Veerle Melotte, Ruth Elizabeth Langley, Matthew Nankivell, David Cunningham, William Allum, Gordon G. Hutchins, Heike Irmgard Grabsch
URN:urn:nbn:de:hebis:30:3-486156
DOI:https://doi.org/10.1016/j.ejca.2018.02.014
ISSN:1879-0852
ISSN:1879-2995
ISSN:0959-8049
ISSN:0014-2964
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/29550565
Parent Title (English):European journal of cancer
Publisher:Elsevier
Place of publication:Amsterdam [u. a.]
Document Type:Article
Language:English
Year of Completion:2018
Date of first Publication:2018/03/20
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2019/01/15
Tag:DNA mismatch repair; Epstein–Barr virus; Gastric cancer; Microsatellite instability; Oesophageal cancer
Volume:94
Page Number:11
First Page:104
Last Page:114
Note:
© 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
HeBIS-PPN:446478377
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung 4.0